HomeTagsBiopharmaceuticals

Biopharmaceuticals

Biotechnology

Inmagene Receives FDA’s IND Clearance for OX40 Antagonist

PR Newswire - May 2, 2022

Inmagene Biopharmaceuticals ("Inmagene") announces that the U.S. Food and Drug Administration (FDA) has cleared drug candidate IMG-007, a monoclonal antibody against OX40, to proceed...

Healthcare

Clover’s COVID-19 Vaccine Candidate Administered as Heterologous Booster in Investigator-Led Phase 2 Clinical Trial

Globe Newswire - November 26, 2021

The Phase 2 trial will evaluate SCB-2019 (CpG 1018/Alum) as a booster dose in individuals previously vaccinated with CoronaVac or recombinant Covid-19 vaccine (AstraZeneca/Fiocruz) Also...